InsidersTradesSigma
Track the 엔케이젠바이오텍코리아 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엔케이젠바이오텍코리아 has logged 1 public disclosures. Market capitalisation: €516.3bn. The latest transaction was disclosed on 22 April 2026 (Other). Among the most active insiders: NKGenBiotech,Inc.. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
엔케이젠바이오텍코리아 es una empresa que opera en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de soluciones biofarmacéuticas innovadoras.